AMNEAL PHARMACT Balance Sheet - Quarterly (NYSE:AMRX)

Add to My Stocks
$17.29 $0.24 (1.41%) AMRX stock closing price Jun 22, 2018 (Closing)
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Cash104.19M181.77M157.65M171.39M157.25M180.13M232.12M366.84M412.17M340.35M
Marketable Securities----------
Receivables294.66M301.95M242.02M219.73M214.01M257.36M239.59M237.45M214.44M324.45M
Inventory158.59M158.47M172.78M200.41M195.56M175.23M167.55M148.07M133.56M125.58M
Raw Materials51.8M51.23M56.15M62.71M52.63M41.07M40.5M39.78M37.8M38.85M
Work In Progress12.51M3.04M6.75M8.76M5.05M3.28M5.95M5.63M5.93M4.41M
Finished Goods94.27M104.18M109.87M128.92M137.87M130.87M121.08M102.66M89.82M82.31M
Notes Receivable----------
Other Current Assets20.21M53.35M60.73M36.93M27.04M18.41M61.31M24.33M22.18M31.68M
Total Current Assets
577.66M695.55M633.19M628.47M593.87M631.14M700.58M776.71M782.37M822.07M
Property Plant & Equipment238.26M240.42M408.23M406.23M406.63M389.68M379.81M368.71M356.81M347.3M
Accumulated Depreciation114.97M115.6M185.03M173.75M166.39M156.31M152.22M145.24M137.41M133.14M
Net Property Plant & Equipment
123.28M124.81M223.19M232.48M240.24M233.37M227.58M223.47M219.4M214.15M
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges--17.09M35.82M37.84M69.86M36.66M---
Intangibles456.32M469.79M717.39M747.98M765.2M827.79M1.1B790.17M805.13M812.18M
Deposits & Other Assets63.62M61.13M58.27M56.34M58.79M60.84M55.2M58.97M79.1M73.75M
Total Assets
1.22B1.35B1.65B1.7B1.7B1.82B2.12B1.85B1.89B1.92B
Notes Payable----------
Accounts Payable65.26M81.09M53.7M56.59M73.35M58.95M61.88M50.51M50.72M56.32M
Current Portion Long-Term Debt17.85M17.84M17.83M17.82M17.81M17.71M17.7M---
Current Portion Capital Leases----------
Accrued Expenses268.67M248.12M252.49M266.08M231.69M244.65M254.94M215.43M251.82M270.43M
Income Taxes Payable----------
Other Current Liabilities-7.17M25M18.74M18.53M-----
Total Current Liabilities
351.79M354.23M349.03M359.24M341.39M321.32M334.53M265.94M302.54M326.76M
Mortgages----------
Deferred Taxes/Income-3.22M1.95M1.35M---38.17M47.46M72.77M
Convertible Debt----------
Long-Term Debt771.21M769.52M767.93M766.46M765.1M813.54M812.37M435.26M429.87M424.59M
Non-Current Capital Leases----------
Other Long-Term Liabilities37.62M37.11M48.3M48.6M48.59M64.17M68.88M37.16M36.98M35.95M
Total Liabilities
1.16B1.16B1.17B1.18B1.16B1.2B1.22B776.54M816.87M860.07M
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus563.97M559.63M554.25M548.28M543.08M535.05M531.3M525.18M518.45M504.07M
Retained Earnings-503M-372.44M-71.37M-22M-1.59M98.19M377.77M557.11M559.81M570.22M
Treasury Stock2.15M2.15M2.15M2.15M2.15M2.15M2.15M2.15M2.15M2.15M
Other Liabilities-1.42M----7.85M-3.8M-7.49M-7.42M-10.46M
Shareholders Equity59.6M187.2M481.93M525.43M540.87M623.97M903.86M1.07B1.07B1.06B
Total Liabilities & Shareholders Equity1.22B1.35B1.65B1.7B1.7B1.82B2.12B1.85B1.89B1.92B
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

AMNEAL PHARMACT Balance Sheet - Key Ratios

Current ratio
1.64
Debt to equity ratio
13.24
Asset turnover ratio
0.44
Receivables turnover
2.88
Price to book ratio
3.47